Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

28.12
-0.4000-1.40%
Post-market: 28.12-0.00050.00%19:59 EDT
Volume:30.49M
Turnover:861.16M
Market Cap:159.88B
PE:37.01
High:28.59
Open:28.45
Low:28.08
Close:28.52
52wk High:29.21
52wk Low:23.62
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.99
T/O Rate:0.54%
Dividend:1.72
Dividend Rate:6.12%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.88
PE(LYR):20.61

Loading ...

$20 Billion In Deals And Counting: Lilly's CEO Targets The "White Space" Of Science For Larger M&A

Options & Short Sell
·
Sep 29

Judge Rejects Pfizer, BioNTech, and Moderna Bid to Dismiss Monsanto mRNA Patent Lawsuit

Stock News
·
Sep 29

How Investors May Respond To Pfizer (PFE) ESMO Cancer Data Showcase

Simply Wall St.
·
Sep 29

AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours

Options & Short Sell
·
Sep 29

Pfizer, Moderna Lose Bids to Escape Bayer US mRNA Patent Lawsuit

Reuters
·
Sep 29

Pfizer's Tilrekimig Phase 3 Program Seen as Potential Upside Driver, UBS Says

MT Newswires Live
·
Sep 28

US Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 28

Pfizer to Present Phase 3 SigVie-002 Survival Data for Sigvotatug Vedotin in Previously Treated NSCLC at ESMO 2026

Reuters
·
Sep 28

Pfizer (PFE) Bets Big on RSV and Cancer Care

TIPRANKS
·
Sep 26

NYSE Most Active Issues

Dow Jones
·
Sep 26

Pfizer Targets Cancer-Related Weight Loss With New Ponsegromab Study

TIPRANKS
·
Sep 26

Pfizer’s RSV Revaccination Trial Targets Durable Booster Revenue in High‑Risk Adults

TIPRANKS
·
Sep 26

C4 Therapeutics Says Cemsidomide-Elranatamab Phase 1b Trial Clears 75 Μg Dose as Safe in Multiple Myeloma

Reuters
·
Sep 25

Moderately bullish activity in Pfizer with shares up 0.9%

TIPRANKS
·
Sep 25

Pfizer’s Japanese RSV Vaccine Study Wraps Up, Expanding Adult Market Potential

TIPRANKS
·
Sep 25

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

Pfizer call volume above normal and directionally bullish

TIPRANKS
·
Sep 24

RBC Capital Remains a Hold on Pfizer (PFE)

TIPRANKS
·
Sep 24

BridgeBio's Heart Drug Shows Superior Real-World Results Over Pfizer's Rival Treatment

Stock News
·
Sep 24

NYSE Most Active Issues

Dow Jones
·
Sep 24